A Trial Comparing GQ1005 and T-DM1 in Patients With HER2-Positive Unresectable or Metastatic Breast Cancer

חו"ל (דורש נסיעה)מגייס משתתפיםPHASE3

מצבים רפואיים

HER2-positive Breast Cancer

סיכום בשפה פשוטהבעזרת בינה מלאכותית

הסיכום נכתב על־ידי מודל שפה והוא ניסיוני. המידע עלול להיות חלקי או שגוי ואינו תחליף לייעוץ רפואי.

מיקומים
  • The First Affiliated Hospital of Bengbu Medical University, Bengbu, Anhui, China

    Contact: Study coordinator (Zhang Mingliang)
  • The Affiliated Fuyang Hospital of Anhui Medical University, Fuyang, Anhui, China

    Contact: Study coordinator (Yingying Du)
  • The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China

    Contact: Study coordinator (Xinghua Han)
  • Anhui Cancer Hospital, Hefei, Anhui, China

    Contact: Study coordinator (Yueyin Pan)
  • The Fifth Medical Center of the Chinese People's Liberation Army General Hospital, Beijing, Beijing Municipality, China

    Contact: Study coordinator (Zefei Jiang)
  • Chongqing University Cancer Hospital, Chongqing, Chongqing Municipality, China

    Contact: Study coordinator (Xianjun Tang)
  • Fujian Cancer Hospital, Fuzhou, Fujian, China

    Contact: Study coordinator (Fan Wu)
  • The Second Affiliated Hospital of Fujian Medical University, Quanzhou, Fujian, China

    Contact: Study coordinator (Jianqing Lin)
  • Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, China

    Contact: Study coordinator (Fei Xu)
  • Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China

    Contact: Study coordinator (Ying Wang)
    Contact: Principal Investigator (Jianli Zhao)
  • Meizhou People's Hospital, Meizhou, Guangdong, China

    Contact: Study coordinator (Jingna Wu)
  • Shantou Central Hospital, Shantou, Guangdong, China

    Contact: Study coordinator (Zhiyong Wu)
  • Guangxi Medical University Cancer Hospital, Nanning, Guangxi, China

    Contact: Study coordinator (Weimin Xie)
  • Guizhou Provincial People's Hospital, Guiyang, Guizhou, China

    Contact: Study coordinator (Yong Li)
  • Guizhou Medical University Cancer Hospital, Guiyang, Guizhou, China

    Contact: Study coordinator (Zhihong Wang)
  • The Affiliated Hospital of Hebei University, Baoding, Hebei, China

    Contact: Study coordinator (Hua Yang)
  • The Affiliated Hospital of Hebei University of Engineering, Handan, Hebei, China

    Contact: Study coordinator (Jianjun Han)
  • The Fourth Hospital of Hebei Medical University, Shijiazhuang, Hebei, China

    Contact: Study coordinator (Yunjiang Liu)
  • Xingtai People's Hospital, Xingtai, Hebei, China

    Contact: Study coordinator (Li Wang)
  • Harbin Medical University Cancer Hospital, Harbin, Heilongjiang, China

    Contact: Study coordinator (Qingyuan Zhang)
  • Anyang Cancer Hospital, Anyang, Henan, China

    Contact: Study coordinator (Jing Sun)
  • Luoyang Central Hospital, Luoyang, Henan, China

    Contact: Study coordinator (Mingli Ni)
  • The First Affiliated Hospital of Henan University of Science and Technology, Luoyang, Henan, China

    Contact: Study coordinator (Xinshuai Wang)
  • The First Affiliated Hospital of Henan Medical University, Xinxiang, Henan, China

    Contact: Study coordinator (Yinghua Ji)
  • Xuchang Central Hospital, Xuchang, Henan, China

    Contact: Study coordinator (Ping Li)
  • Henan Cancer Hospital, Zhengzhou, Henan, China

    Contact: Study coordinator (Min Yan)
  • The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China

    Contact: Study coordinator (Fang Wang)
  • Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China

    Contact: Study coordinator (Yanxia Zhao)
  • Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China

    Contact: Study coordinator (Huihua Xiong)
  • Renmin Hospital of Wuhan University, Wuhan, Hubei, China

    Contact: Study coordinator (Feng Yao)
  • Zhongnan Hospital of Wuhan University, Wuhan, Hubei, China

    Contact: Study coordinator (Haijun Yu)
  • Hubei Cancer Hospital, Wuhan, Hubei, China

    Contact: Study coordinator (Xinhong Wu)
  • Hunan Cancer Hospital, Changsha, Hunan, China

    Contact: Study coordinator (Quchang Ouyang)
  • Yongzhou Central Hospital, Yongzhou, Hunan, China

    Contact: Study coordinator (Sijuan Du)
  • Xuzhou Central Hospital, Xuzhou, Jiangsu, China

    Contact: Study coordinator (Yanhua Liu)
  • Ganzhou Cancer Hospital, Ganzhou, Jiangxi, China

    Contact: Study coordinator (Yongqiang Ye)
  • Nanchang People's Hospital, Nanchang, Jiangxi, China

    Contact: Study coordinator (Yili Wang)
  • The First Hospital of Jilin University, Changchun, Jilin, China

    Contact: Study coordinator (Jiuwei Cui)
  • The Second Affiliated Hospital of Dalian Medical University, Dalian, Liaoning, China

    Contact: Study coordinator (Man Li)
  • The First Affiliated Hospital of Jinzhou Medical University, Jinzhou, Liaoning, China

    Contact: Study coordinator (Zhenhua Zhai)
  • The First Affiliated Hospital of China Medical University, Shenyang, Liaoning, China

    Contact: Study coordinator (Yuee Teng)
  • Liaoning Cancer Hospital, Shenyang, Liaoning, China

    Contact: Study coordinator (Tao Sun)
  • The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China

    Contact: Study coordinator (Shuqun Zhang)
  • The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China

    Contact: Study coordinator (Jin Yang)
  • Shandong Cancer Hospital, Jinan, Shandong, China

    ZhiyongYu
  • The Second People's Hospital of Liaocheng City, Linqing, Shandong, China

    Contact: Study coordinator (Yanjun Wang)
  • Linyi Cancer Hospital, Linyi, Shandong, China

    Contact: Study coordinator (Jingfen Wang)
  • Linyi Central Hospital, Linyi, Shandong, China

    Contact: Study coordinator (Yuzhou Li)
  • The Affiliated Hospital of Qingdao University, Qingdao, Shandong, China

    WenfengLi
  • Yidu Central Hospital of Weifang City, Qingzhou, Shandong, China

    Contact: Study coordinator (Peng Wang)
  • Weifang People's Hospital, Weifang, Shandong, China

    Contact: Study coordinator (Wenhui Wang)
  • Yantai Yuhuangding Hospital, Yantai, Shandong, China

    Contact: Study coordinator (Ping Sun)
  • Fudan University Shanghai Cancer Center, Shanghai, Shanghai Municipality, China

    Contact: Study coordinator (Biyun Wang)
  • Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, Shanghai Municipality, China

    Contact: Study coordinator (Jinsong Lu)
  • Shanghai Gaobo Cancer Hospital, Shanghai, Shanghai Municipality, China

    Contact: Study coordinator (Shuang Li)
  • Shanxi Cancer Hospital, Taiyuan, Shanxi, China

    Contact: Study coordinator (Guohui Han)
  • The Third People's Hospital of Chengdu City, Chengdu, Sichuan, China

    Contact: Study coordinator (Zhume Luo)
  • West China Hospital of Sichuan University, Chengdu, Sichuan, China

    Contact: Study coordinator (Ting Luo)
  • Deyang People's Hospital, Deyang, Sichuan, China

    Contact: Study coordinator (Xinjian Jia)
  • The Second People's Hospital of Neijiang City, Neijiang, Sichuan, China

    Contact: Study coordinator (Xujuan Wang)
  • Suining Central Hospital, Suining, Sichuan, China

    Contact: Study coordinator (Hongwei Yang)
  • Tianjin Cancer Hospital, Tianjin, Tianjin Municipality, China

    Contact: Study coordinator (Yehui Shi)
  • Yunnan Cancer Hospital, Kunming, Yunnan, China

    Contact: Study coordinator (Wenlin Chen)
  • The First People's Hospital of Hangzhou City, Hangzhou, Zhejiang, China

    Contact: Study coordinator (Jian Liu)
  • Women's Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China

    Contact: Study coordinator (Jingpei Long)
  • The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, Zhejiang, China

    Contact: Study coordinator (Fuming Qiu)
  • Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China

    Contact: Study coordinator (Xian Wang)
  • Zhejiang Cancer Hospital, Hangzhou, Zhejiang, China

    Contact: Study coordinator (Yabing Zheng)
  • The First People's Hospital of Xiaoshan District, Hangzhou City, Hangzhou, Zhejiang, China

    Contact: Study coordinator (Zhenyu Wang)
  • The Affiliated People's Hospital of Ningbo University, Ningbo, Zhejiang, China

    Contact: Study coordinator (Zhengyang Xu)
מובילי המחקר
  • Zefei Jiang, M.D.

    Principal Investigator

    The Fifth Medical Center of the Chinese People's Liberation Army General Hospital